EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 12 (Décembre 2010) Med Sci (Paris), 26 12 (2010) 1040-1042 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 12, Décembre 2010
Page(s) 1040 - 1042
Section Nouvelles
DOI https://doi.org/10.1051/medsci/201026121040
Published online 15 December 2010
  1. Cannistra SA. Cancer of the ovary. N Engl J Med 2004 ; 351 : 2519-29. [Google Scholar]
  2. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and résistance to platinium-based chemotherapy. Cancer 2000 ; 88 : 2584-9. [Google Scholar]
  3. Crotzer DR, Sun CC, Coleman RL, et al. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Gynecol Oncol 2007 ; 105 : 404-8. [Google Scholar]
  4. Viganò P, Somigliana E, Chiodo I, et al. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Update 2006 ; 12 : 77-89. [Google Scholar]
  5. Kuo KT, Mao TL, Chen X, et al. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma. Clin Cancer Res 2010 ; 16 : 1997-2008. [Google Scholar]
  6. Kuo KT, Mao TL, Jones S, et al. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 2009 ; 174 : 1597-601. [Google Scholar]
  7. Jones S, Wang TL, Shih I-M, et al. Fréquent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010 ; 330 : 228-31. [Google Scholar]
  8. Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010 ; 363 : 1532-43 [Google Scholar]
  9. Huang J, Zhao YL, Li Y, et al. Genomic and functional evidence for an ARID1A tumor suppressor role. Genes Chromosomes Cancer 2007 ; 46 : 745-50. [Google Scholar]
  10. Li XS, Trojer P, Matsumura T, et al. Mammalian SWI/ SNF-a subunit BAF250/ARID1A is an E3 ubiquitin ligase that targets histone H2B. Mol Cell Biol 2010 ; 30 : 1673-88. [Google Scholar]
  11. Bernard OA, Delhommeau F, Fontenay M, Vainchenker W. Mutations du gène TET2 dans les hémopathies myéloïdes humaines. Med Sci (Paris) 2009 ; 25 : 785-8. [Google Scholar]
  12. Deltour S, Chopin V, Leprince D. Modifications épigénétiques et cancer. Med Sci (Paris) 2005 ; 21 : 405-11. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.